Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
- 1 April 1998
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 104 (4), 332-338
- https://doi.org/10.1016/s0002-9343(98)00060-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous ThromboembolismNew England Journal of Medicine, 1997
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- The Management of Thrombosis in the Antiphospholipid-Antibody SyndromeNew England Journal of Medicine, 1995
- Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?Lupus, 1994
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsAmerican Journal Of Medicine, 1994
- Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.Annals Of The Rheumatic Diseases, 1993
- Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous ThrombosisAnnals of Internal Medicine, 1992
- Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 PatientsAnnals of Internal Medicine, 1992
- Antiphospholipid syndrome: five year follow up.Annals Of The Rheumatic Diseases, 1991
- Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.Annals Of The Rheumatic Diseases, 1985